Navigation Links
Behind The Ear -- A New Site To Measure for Fever
Date:12/15/2011

SOUTHBOROUGH, Mass., Dec. 15, 2011 /PRNewswire/ -- For parents, knowing how to take a child's temperature the correct way and whether environmental factors like sweat or drafts affect the accuracy of results can be a guessing game.  The new Vicks® Behind Ear Thermometer (V980) takes the guesswork out of measuring for fever, restoring confidence to parents and peace of mind.  Using patented technology, the Vicks® Behind Ear Thermometer features rapid 1-second readings and is the first thermometer designed exclusively to measure temperature from behind the ear, a gentler, non-invasive approach to detecting fever than rectal, under-the-tongue, and forehead measurements.  Clinically proven to be accurate based upon professional standards, the Vicks Behind Ear Thermometer is an easy and reliable tool helping parents know when fever is getting better or worse at a glance.  

(Photo:  http://photos.prnewswire.com/prnh/20111215/NE22936 )

"For most parents, temperature taking can be a daunting task.  Aside from squeamishness around rectal measurements, parents are often concerned about the reliability of thermometers and having to wake a sick child for a reading.  I'm excited that the Vicks Behind Ear Thermometer is now a solution for moms and dads that addresses all these concerns," said Dr. Jennifer Trachtenberg, MD, FAAP, pediatrician at The Mount Sinai Medical Center in New York and Fellow of the American Academy of Pediatrics.  "The soft hollow site behind the ear is very close to the carotid artery, which carries blood to the brain.  This spot is easily accessible and ideal for accurate measurements as it is naturally protected from factors like perspiration and drafts that can often cause misreading."

The Vicks Behind Ear Thermometer i
'/>"/>

SOURCE Kaz
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Pharmaceutical and Biotech Executives Must Manage and Optimize Key Opinion Leaders or Fall Behind in the Marketplace
2. TechniScan Cofounder to Speak at SPIE Medical Imaging Conference About Ground-Breaking Science Behind the Companys Ultrasound Technology
3. Sanofi-aventis Stands Behind the Safety of Lantus(R)
4. Kibow Biotech Obtains Australian, Chinese and Indian Patents Protecting the Composition and Basic Technology Behind Its Oral Probiotic Formulation for Chronic Kidney Failure
5. Cleveland Clinic Researchers Identify Mechanism Behind Platelet Function and Potentially Fatal Blood Clot Formation
6. United States Anesthesia and Respiratory Devices Market Outlook to 2017 - Respiratory Devices, Respiratory Measurement Devices, Airway and Anesthesia Devices, Anesthesia Machines, Sleep Apnea Diagnostic Systems, Pain Management Devices and Others
7. Long-term Use of Antiepileptic Drug Vimpat® (Lacosamide) C-V Reduced Seizure Frequency and Severity and Improved Health-related Quality of Life Measures
8. ADVISE Study Results Demonstrate the Instant Wave-Free Ratio™, a Vasodilator-Free Measure of Stenosis Severity, is Comparable to FFR
9. New Data on Patient-Reported Improvements in Quality of Life Measures and Other Clinical Responses in Moderate to Severe Rheumatoid Arthritis Patients Taking Cimzia® (certolizumab pegol) Highlighted at American College of Rheumatology Meeting
10. FDA Approves U.S. Market Return for octagam® Following Octapharmas Implementation of Enhanced Safety Measures
11. New Research Shows Chronic Pain is not Being Adequately Measured[1]
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/1/2015)... 2015  Amgen (NASDAQ: AMGN ) today ... areas of Alzheimer,s disease and migraine. The collaboration ... teaming up with Novartis on a differentiated and ... predisposed individuals at risk of developing Alzheimer,s disease. ... commercialization of its migraine programs in the U.S., ...
(Date:9/1/2015)... , Sept. 1, 2015 Nevro Corp. (NYSE: ... is providing innovative evidence-based solutions for the treatment of ... its preliminary response to the Patent Trial and Appeals ... inter partes review (IPR), filed by a unit of ... in U.S. Patent No. 8,359,102 (the ,102 patent). The ,102 ...
(Date:9/1/2015)... THOUSAND OAKS, Calif. and ... (NASDAQ: AMGN ) and UCB (Euronext Brussels: ... trial (STudy evaluating effect of RomosozUmab Compared with ... risk for fracture pReviously treated with bisphosphonatE therapy). ... a statistically significant difference in favor of romosozumab ...
Breaking Medicine Technology:Amgen Enters Into Neuroscience Collaboration With Novartis For Alzheimer's Disease And Migraine Programs 2Amgen Enters Into Neuroscience Collaboration With Novartis For Alzheimer's Disease And Migraine Programs 3Amgen Enters Into Neuroscience Collaboration With Novartis For Alzheimer's Disease And Migraine Programs 4Amgen Enters Into Neuroscience Collaboration With Novartis For Alzheimer's Disease And Migraine Programs 5Amgen Enters Into Neuroscience Collaboration With Novartis For Alzheimer's Disease And Migraine Programs 6Amgen Enters Into Neuroscience Collaboration With Novartis For Alzheimer's Disease And Migraine Programs 7Amgen Enters Into Neuroscience Collaboration With Novartis For Alzheimer's Disease And Migraine Programs 8Amgen Enters Into Neuroscience Collaboration With Novartis For Alzheimer's Disease And Migraine Programs 9Nevro Announces Submission of Preliminary Response to the Patent Trial and Appeals Board 2Amgen And UCB Announce Positive Top-Line Results From Open-Label Phase 3 Study Of Romosozumab Compared With Teriparatide 2Amgen And UCB Announce Positive Top-Line Results From Open-Label Phase 3 Study Of Romosozumab Compared With Teriparatide 3Amgen And UCB Announce Positive Top-Line Results From Open-Label Phase 3 Study Of Romosozumab Compared With Teriparatide 4Amgen And UCB Announce Positive Top-Line Results From Open-Label Phase 3 Study Of Romosozumab Compared With Teriparatide 5Amgen And UCB Announce Positive Top-Line Results From Open-Label Phase 3 Study Of Romosozumab Compared With Teriparatide 6Amgen And UCB Announce Positive Top-Line Results From Open-Label Phase 3 Study Of Romosozumab Compared With Teriparatide 7Amgen And UCB Announce Positive Top-Line Results From Open-Label Phase 3 Study Of Romosozumab Compared With Teriparatide 8Amgen And UCB Announce Positive Top-Line Results From Open-Label Phase 3 Study Of Romosozumab Compared With Teriparatide 9
... N.Y., Jan. 20, 2011 Whenever someone needs high-quality drugs ... place their order. However, because of the large choice of ... decision. Rx-webmasters.com was launched to make things simpler and safer ... purchase any other drugs. The website promotion is the responsibility ...
... Jan. 19, 2011 Boston Scientific Corporation (NYSE: ... subsidiary, Boston Scientific Japan K.K., has reached an ... and sell its cardiac rhythm management (CRM) devices ... resources, distribution network and service capabilities will complement ...
Cached Medicine Technology:New Online Pharmacy Rx-webmasters.com Allows Customers to Pay Less for High-Quality Drugs 2Boston Scientific Announces Agreement With Fukuda Denshi for Distribution of Cardiac Rhythm Management Products in Japan 2Boston Scientific Announces Agreement With Fukuda Denshi for Distribution of Cardiac Rhythm Management Products in Japan 3
(Date:9/1/2015)... ... 2015 , ... From Aug. 17-21, Calvary Hospital hosted the 18th consecutive session ... Compass® has taken place at Kingsborough Community College in Brooklyn in each of the ... for Calvary, and two junior counselors who were campers themselves just a few years ...
(Date:9/1/2015)... Jersey (PRWEB) , ... September 01, 2015 , ... Horizon ... of the 50 Best Companies for Latinas in the LATINA Style 50 Report that ... States. , For 2015, Horizon BCBSNJ climbs from number 24 to ...
(Date:9/1/2015)... London, UK (PRWEB) , ... ... ... are constantly seeking better therapeutic options to efficiently cure and prevent different ... classes. Different cancers have different pathophysiological properties due to which distinctive approach ...
(Date:9/1/2015)... ... September 01, 2015 , ... As part of its ... Shield of Minnesota (Blue Cross) has announced Doctor On Demand as the company’s ... Doctor On Demand provides immediate access to Board Certified physicians or next-day appointments ...
(Date:9/1/2015)... UK (PRWEB) , ... September 01, 2015 , ... ... a vacuum that creates negative pressure inside a wound to remove exudates, fluid, ... for treatment devices (comprising portable devices, stand-alone devices, disposable devices, and canisters, etc.) ...
Breaking Medicine News(10 mins):Health News:Calvary Hospital Hosts 18th Annual Bereavement Camp 2Health News:Calvary Hospital Hosts 18th Annual Bereavement Camp 3Health News:Horizon Blue Cross Blue Shield of New Jersey Named One of the 50 Best Companies for Latinas by Latina Style Magazine 2Health News:Horizon Blue Cross Blue Shield of New Jersey Named One of the 50 Best Companies for Latinas by Latina Style Magazine 3Health News:CD Antigen Cancer Market and Pipeline Landscape Examined in Comprehensive Kuick Research Report Published at MarketPublishers.com 2Health News:CD Antigen Cancer Market and Pipeline Landscape Examined in Comprehensive Kuick Research Report Published at MarketPublishers.com 3Health News:Blue Cross and Blue Shield of Minnesota names Doctor On Demand as preferred telehealth destination 2Health News:Blue Cross and Blue Shield of Minnesota names Doctor On Demand as preferred telehealth destination 3Health News:World Negative Pressure Wound Therapy Market Assessed by GlobalData in In-demand Report Published at MarketPublishers.com 2Health News:World Negative Pressure Wound Therapy Market Assessed by GlobalData in In-demand Report Published at MarketPublishers.com 3
... the FDA and pharmaceutical manufacturers contemplate the development ... extended release opioids, thousands of clinicians who treat ... resource that supports the safe and effective use ... ( www.emergingsolutionsinpain.com ) is a multi-award winning, ...
... do more to promote awareness, study says , , FRIDAY, Feb. ... by name or role -- the doctors assigned to their ... , "The majority of hospitalized patients we looked at were ... said study author Dr. Vineet Arora, associate program director at ...
... MA A new national survey conducted by the Harvard ... finds that the vast majority (93%) of Americans have heard ... Among those who are aware of the recall, about six ... precautions to reduce their risk of getting sick from contaminated ...
... bid to help underserved children, the Children,s Health Fund ... Radiology System, donated by Siemens. Bidding for the ... quarter million dollars in the first ten days. ... at: , http://inr.mediaseed.tv/oneClip_C/?feed=EEHPWrm_uGEQOCdpx2JU_mPv2Er3Cvod The winning bid was ...
... Tests in mice were successful, and human trials are ... -- A new herbal formula based in ancient Chinese ... peanuts and other foods, researchers from New York City,s ... are potentially life-threatening for children and adults. Food allergies ...
... SALT LAKE CITY, Feb. 13 Dynatronics Corporation (Nasdaq: ... quarter and six months ended December 31, 2008. Operating results ... December 31, 2007. Pre-tax profit for the quarter ended December ... of $521,656 for the second quarter of the prior fiscal ...
Cached Medicine News:Health News:Opioid Safety and Efficacy Web Resource for Clinicians Supports Education and Practice Needs 2Health News:Opioid Safety and Efficacy Web Resource for Clinicians Supports Education and Practice Needs 3Health News:Many Hospital Patients Can't ID Their Doctors 2Health News:Many Hospital Patients Can't ID Their Doctors 3Health News:Following peanut product recall, six in ten Americans taking steps to reduce risk of sickness 2Health News:Following peanut product recall, six in ten Americans taking steps to reduce risk of sickness 3Health News:Herbal Remedy Could Halt Peanut Allergy 2Health News:Herbal Remedy Could Halt Peanut Allergy 3Health News:Dynatronics Reports Profitable Second Quarter - Signaling Significant Improvement Over Prior Year Results 2Health News:Dynatronics Reports Profitable Second Quarter - Signaling Significant Improvement Over Prior Year Results 3Health News:Dynatronics Reports Profitable Second Quarter - Signaling Significant Improvement Over Prior Year Results 4
... Needles are preominantly used for routine blood ... colour of the needle protective cap simplifies ... For example, yellow symbolises the needle dimension ... (0.80 mm) and black 22 G (0.70 ...
DiaMed-ID Micro Typing System...
Bio-Rad's ScanGel® cards for ABO reverse grouping, antibody screening and crossmatching include - ScanGel Neutral, ScanGel Coombs, Anti-IgG, -C3d (AHG), ScanGel Coombs + Neutral, ScanGel Anti-Ig...
... cell runs up to 12 mini gels ... Handcast gels can be poured 12 at ... gradient former and Mini-PROTEAN 3 multi-casting chamber, ... Alternatively, Ready Gel precast gels offer the ...
Medicine Products: